No Impact on IGF-1 or Blood Sugar Levels Unlike full growth hormone therapy, which can increase IGF-1 and affect glucose metabolism, AOD-9604: Does not elevate IGF-1 levels, reducing the risk of unwanted anabolic effects or organ enlargement
The trouble with this is you may have difficulty with the needles, etc
Highest documentation standard: FDA-registered manufacturers (Hospira, Fresenius Kabi) with per-lot COAs, NDC-traceable product, and cGMP manufacturing
Monitoring Progress: Initial testing allows us to track your improvement over time, adjusting dosages to ensure you achieve sustained energy, optimal wellness, and mental clarity safely and effectively
Therefore, for CY 2026, we are finalizing without modification the APCs and status indicators for the CPT codes listed in Table 96
Dosing is extrapolated from preclinical models [1] [6]